Your browser doesn't support javascript.
loading
CDK6 is activated by the atypical cyclin I to promote E2F-mediated gene expression and cancer cell proliferation.
Quandt, Eva; Masip, Núria; Hernández-Ortega, Sara; Sánchez-Botet, Abril; Gasa, Laura; Fernández-Elorduy, Ainhoa; Plutta, Sara; Martínez-Láinez, Joan Marc; Bru, Samuel; Munoz-Torres, Pau M; Floor, Martin; Villà-Freixa, Jordi; Morris, May C; Vidal, August; Villanueva, Alberto; Clotet, Josep; Ribeiro, Mariana P C.
Afiliação
  • Quandt E; Basic Science Department, Faculty of Medicine and Health Sciences, Universitat Internacional de Catalunya, Barcelona, Spain.
  • Masip N; Basic Science Department, Faculty of Medicine and Health Sciences, Universitat Internacional de Catalunya, Barcelona, Spain.
  • Hernández-Ortega S; Basic Science Department, Faculty of Medicine and Health Sciences, Universitat Internacional de Catalunya, Barcelona, Spain.
  • Sánchez-Botet A; Basic Science Department, Faculty of Medicine and Health Sciences, Universitat Internacional de Catalunya, Barcelona, Spain.
  • Gasa L; Basic Science Department, Faculty of Medicine and Health Sciences, Universitat Internacional de Catalunya, Barcelona, Spain.
  • Fernández-Elorduy A; Basic Science Department, Faculty of Medicine and Health Sciences, Universitat Internacional de Catalunya, Barcelona, Spain.
  • Plutta S; Basic Science Department, Faculty of Medicine and Health Sciences, Universitat Internacional de Catalunya, Barcelona, Spain.
  • Martínez-Láinez JM; Basic Science Department, Faculty of Medicine and Health Sciences, Universitat Internacional de Catalunya, Barcelona, Spain.
  • Bru S; Basic Science Department, Faculty of Medicine and Health Sciences, Universitat Internacional de Catalunya, Barcelona, Spain.
  • Munoz-Torres PM; Institut de Neurociències, Universitat Autònoma de Barcelona, Bellaterra (Cerdanyola del Vallès), Spain.
  • Floor M; Basic Science Department, Faculty of Medicine and Health Sciences, Universitat Internacional de Catalunya, Barcelona, Spain.
  • Villà-Freixa J; Department of Biosciences, Faculty of Sciences, Technology and Engineering, Universitat de Vic - Universitat Central de Catalunya, Spain.
  • Morris MC; Basic Science Department, Faculty of Medicine and Health Sciences, Universitat Internacional de Catalunya, Barcelona, Spain.
  • Vidal A; Department of Biosciences, Faculty of Sciences, Technology and Engineering, Universitat de Vic - Universitat Central de Catalunya, Spain.
  • Villanueva A; Institut des Biomolécules Max Mousseron, CNRS-UMR5247, Université de Montpellier, France.
  • Clotet J; Servei d'Anatomia Patològica, Hospital Universitari de Bellvitge, Barcelona, Spain.
  • Ribeiro MPC; Oncobell Program, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Barcelona, Spain.
Mol Oncol ; 17(7): 1228-1245, 2023 07.
Article em En | MEDLINE | ID: mdl-37081792
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Ciclina I Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Ciclina I Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article